Wire · opportunities
FDA authorizes first dual glucose-ketone monitor for children as young as 2
◆ Sectors
◆ Geography
◆ Source
◆ Verified
Fusion42 · 25 August 2026 · Fusion42 review
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable device to continuously monitor both glucose and ketone levels in patients aged 2 and older with diabetes, through the De Novo premarket pathway.
This Wire brief sits within Fusion42's coverage of Medtech, and 2 sources have reported it between 25 Aug 2026 and 26 Aug 2026.
◆ ◆ The Wire takeaway
You can now offer continuous ketone monitoring to young diabetes patients, a clinical gap that routine glucose tracking misses. Abbott’s device opens a new route for early intervention services and product integration in paediatric diabetes care.
◆ Coverage
2 sources · first reported 25 Aug 2026 · latest 26 Aug 2026
◆ Related on Wire
◆ Topics